Temple Beth Elohim is graciously hosting this Oneinforty symposium to educate the community about Ashkenazi Jews’ one-in-forty risk of inheriting a BRCA gene mutation. People who have a BRCA mutation are at relatively high risk for developing ovarian, prostate and male and female breast cancer.
Come learn about genetic counseling, screening for BRCA mutations, misconceptions about hereditary cancer, how BRCA-positive individuals can manage their risk of developing cancer, emotional support resources available for you and your family and the new BRCA Founder Outreach (BFOR) Study being conducted by Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Several people who are BRCA-positive and cancer survivors will share their stories.
Following presentations by each of these panelists, there will be a Q&A session:
Founder & Executive Director
BRCA-positive ovarian cancer survivor
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Massachusetts General Hospital
Debbi Shamon, LICSW
In private practice in Boston
This symposium is open to the general public. Kosher refreshments will be served.
Feel free to contact Lauren Corduck at firstname.lastname@example.org or 617-823-3630 with any questions you may have about the symposium.+ More... - Less...
* Registration closes on May 24th
10 Bethel Rd
Wellesley, MA 02481